AIRLINK 212.82 Increased By ▲ 3.27 (1.56%)
BOP 10.25 Decreased By ▼ -0.21 (-2.01%)
CNERGY 7.00 Decreased By ▼ -0.35 (-4.76%)
FCCL 33.47 Decreased By ▼ -0.92 (-2.68%)
FFL 17.64 Decreased By ▼ -0.41 (-2.27%)
FLYNG 21.82 Decreased By ▼ -1.10 (-4.8%)
HUBC 129.11 Decreased By ▼ -3.38 (-2.55%)
HUMNL 13.86 Decreased By ▼ -0.28 (-1.98%)
KEL 4.86 Decreased By ▼ -0.17 (-3.38%)
KOSM 6.93 Decreased By ▼ -0.14 (-1.98%)
MLCF 43.63 Decreased By ▼ -1.57 (-3.47%)
OGDC 212.95 Decreased By ▼ -5.43 (-2.49%)
PACE 7.22 Decreased By ▼ -0.36 (-4.75%)
PAEL 41.17 Decreased By ▼ -0.53 (-1.27%)
PIAHCLA 16.83 Decreased By ▼ -0.47 (-2.72%)
PIBTL 8.63 Increased By ▲ 0.08 (0.94%)
POWER 8.81 Increased By ▲ 0.03 (0.34%)
PPL 183.03 Decreased By ▼ -6.00 (-3.17%)
PRL 39.63 Decreased By ▼ -2.70 (-6.38%)
PTC 24.73 Decreased By ▼ -0.44 (-1.75%)
SEARL 98.01 Decreased By ▼ -5.95 (-5.72%)
SILK 1.01 Decreased By ▼ -0.02 (-1.94%)
SSGC 41.73 Increased By ▲ 2.49 (6.35%)
SYM 18.86 Decreased By ▼ -0.30 (-1.57%)
TELE 9.00 Decreased By ▼ -0.24 (-2.6%)
TPLP 12.40 Decreased By ▼ -0.70 (-5.34%)
TRG 65.68 Decreased By ▼ -3.50 (-5.06%)
WAVESAPP 10.98 Increased By ▲ 0.26 (2.43%)
WTL 1.79 Increased By ▲ 0.08 (4.68%)
YOUW 4.03 Decreased By ▼ -0.11 (-2.66%)
BR100 11,866 Decreased By -213.1 (-1.76%)
BR30 35,697 Decreased By -905.3 (-2.47%)
KSE100 114,148 Decreased By -1904.2 (-1.64%)
KSE30 35,952 Decreased By -625.5 (-1.71%)

Local pharmaceutical industry has lauded the Drug Regulatory Authority's initiative to establish model pharmacies across the country to ensure availability of life-saving drugs as their shortage costs many lives. The DRAP has issued a notification indicating that 14 model pharmacies will be established in Islamabad, Karachi, Lahore and other big cities of the country in the first phase.
A pharma industry source said that it has always been a challenge for the DRAP to curb the menace of fake drugs and the authority has taken great pains to ensure quality of drugs available in the market.
"However, the DRAP has to ensure quality of the drugs as fake and spurious drugs kill thousands of people every year," he added. According to him, Pakistan faces the illegitimate but lucrative trade of counterfeit and substandard drugs to the epidemic proportions. According to the World Health Organization (WHO), each pharmaceutical product that a manufacturer produces has to comply with quality standards and specifications at release and throughout the product shelf-life required by the territory of use.
The WHO estimates that only approximately 20 percent of its 191 member states have well-developed drug regulation; around 30 percent are thought to have no or minimal drug regulation in place.
"In Pakistan, poor-quality medicines pose a serious public health problem as the vested interests make every possible effort to make availability of deliberately falsified and substandard medicines in the market," he added.
It has also been reported that fake insulin is being excessively used in Balochistan and many cases have been spotted in Turbat where fake insulin is being supplied under the name of famous company.
Another issue is unavailability of qualified pharmacists as they usually leave Pakistan to work in the US and European and Middle Eastern countries due to lack of attractive employment prospects here in the local market, industry sources said, adding: "These model pharmacies will help stop the brain drain of qualified pharmacists in the country by providing them job opportunities locally." Hundreds of people are dying in Pakistan due to ignorance of the properties of modern medicines and their adverse reactions, complications and interactions with other drugs. Hence, the DRAP has to ensure quality of drugs at these model pharmacies with qualified pharmacists on their panel to make this step beneficial for the patient, the sources said.

Copyright Business Recorder, 2019

Comments

Comments are closed.